GSK's former head of vaccines R&D – Dr Emmanuel Hanon – is heading up a new biotech called Vicebio that will go up against his former employer with a vaccine against respiratory syncytial ...

Furie V, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2020;79(1):39–52. DOI: 10.1136/annrheumdis ...

Kiltz U, et al. Tolerability and safety of recombinant zoster vaccine in patients with inflammatory rheumatic musculoskeletal diseases - a prospective longitudinal study over 12 months.

Patients with ARDs who received RTX demonstrated impaired humoral responses to RZV, compared with healthy controls and individuals with ARDs not exposed to RTX.

Medicare Part D provides coverage for the shingles vaccine, also called Shingrix. Since 2023, people enrolled in Part D coverage pay nothing out-of-pocket for the Shingrix vaccine.

In the original study of the efficacy of herpes zoster (HZ) vaccine, vaccination was associated with 51% fewer HZ cases (JW Gen Med Jul 1 2005, p. 103, and N Engl J Med 2005; 352:2271).

New work presented at the 2025 annual EULAR congress in Barcelona focuses on the recombinant zoster vaccine (RZV), which contains recombinant glycoprotein E - the major target of CD4+T-cells.

Liz Turpin, Vice President of BioProcess at TARGAN, brings a unique blend of expertise to her role as an entrepreneur, ...

Gammagard Liquid ERC is a ready-to-use formulation with low IgA content designed to ease administration burden by removing the need to reconstitute.

The zoster vaccine is effective, well tolerated, and recommended for routine administration by national guidelines; however, most older adults do not receive it. The main barrier to dissemination ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new study.